Overview

A Clinical Trial to Evaluate Efficacy and Safety of Two Different Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis

Status:
Completed

Trial end date:
2020-12-03

Target enrollment:

Participant gender:

Summary

This study is a Phase III, multicentre, randomized, observer blind, parallel group, three arms, controlled clinical trial to evaluate the efficacy and safety of topically applied Calcipotriol/AKVANO 50 μg/g cutaneous solution against Calcipotriol Ointment 50 micrograms/g, Sandoz and placebo in patients with mild to moderate plaque psoriasis

Phase:

Phase 3

Details

Lead Sponsor:

Cadila Pharnmaceuticals

Collaborator:

Lipidor AB, Svärdvägen 13 SE-182 33 Danderyd, Sweden

Treatments:

Calcipotriene
Calcitriol